Hearing impairment has emerged as a potential risk factor for Parkinson’s disease, a progressive neurodegenerative disorder that primarily manifests with motor impairments like tremors, rigidity, and ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

Parkinson’s Disease has over 40 wide-ranging symptoms, as per the charity, from tremors and mental health issues to blood pressure changes. Those with Parkin 2 often experience these symptoms at ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

21, 2025 — The B vitamin mitigates manganese neurotoxicity, which produces symptoms ... motor function, offering a new therapeutic ... A Risky Business: Why Do Some Parkinson's Disease ...

This pivotal study investigates the potential of specialized phototherapy to improve both non-motor and motor symptoms of Parkinson's disease (PD) beyond current best medical care, aiming to ...

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...

Movement is key in helping to control symptoms of Parkinson’s disease (PD). To help promote the benefits of cycling as it ...